Trials / Unknown
UnknownNCT03618706
Standard of Care Therapy With Involved Field Radiation Therapy for Selective Recurrent Ovarian Cancer
A Phase II Trial of Standard of Care Therapy With Involved Field Radiation Therapy for Selective Recurrent Ovarian Cancer
- Status
- Unknown
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 107 (estimated)
- Sponsor
- Yonsei University · Academic / Other
- Sex
- All
- Age
- 19 Years
- Healthy volunteers
- Not accepted
Summary
This study aims to investigate the effect of involved-field radiotherapy for recurrent ovarian cancer after primary standard treatment. We will investigate whether the addition of involved-field RT improves 2-year PFS in those patients than that of historical data (only with other standard salvage treatments as systemic chemotherapy ± maximum tumor resection).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| RADIATION | Involved-field radiotherapy | After the diagnosis of recurrences, patients will receive involved-field radiotherapy (gross tumor volume + margin) with any radiation dose scheme (≥45 Gy Biological Equivalent dose) as physician's discretion. |
Timeline
- Start date
- 2018-05-10
- Primary completion
- 2023-05-09
- Completion
- 2023-05-09
- First posted
- 2018-08-07
- Last updated
- 2018-08-07
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT03618706. Inclusion in this directory is not an endorsement.